Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank79
3Y CAGR-0.7%
5Y CAGR+5.0%
Year-over-Year Change
Research and development spending
3Y CAGR
-0.7%/yr
vs +6.7%/yr prior
5Y CAGR
+5.0%/yr
Recent deceleration
Acceleration
-7.4pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $98.97M | -14.2% |
| 2024 | $115.38M | +10.7% |
| 2023 | $104.19M | +3.0% |
| 2022 | $101.19M | +8.8% |
| 2021 | $93.05M | +20.3% |
| 2020 | $77.38M | -2.8% |
| 2019 | $79.57M | +2.0% |
| 2018 | $78.04M | +23.0% |
| 2017 | $63.45M | +9.1% |
| 2016 | $58.16M | - |